1 Min Read
May 30 (Reuters) - Regulus Therapeutics Inc
* EcoR1 Capital LLLC reports a 9.6 percent passive stake in Regulus Therapeutics Inc as of May 17 - SEC filing Source text for Eikon: (bit.ly/2r8sCMk) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.